BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28052106)

  • 1. A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information.
    Silva-Alves MS; Secolin R; Carvalho BS; Yasuda CL; Bilevicius E; Alvim MK; Santos RO; Maurer-Morelli CV; Cendes F; Lopes-Cendes I
    PLoS One; 2017; 12(1):e0169214. PubMed ID: 28052106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy.
    López-García MA; Feria-Romero IA; Serrano H; Rayo-Mares D; Fagiolino P; Vázquez M; Escamilla-Núñez C; Grijalva I; Escalante-Santiago D; Orozco-Suarez S
    Pharmacol Rep; 2017 Jun; 69(3):504-511. PubMed ID: 28343093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major vault protein (MVP) gene polymorphisms and drug resistance in mesial temporal lobe epilepsy with hippocampal sclerosis.
    Balan S; Radhab SK; Sathyan S; Vijai J; Banerjee M; Radhakrishnan K
    Gene; 2013 Sep; 526(2):449-53. PubMed ID: 23751308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population.
    Al-Eitan LN; Rababa'h DM; Alghamdi MA; Khasawneh RH
    BMC Med Genet; 2019 Sep; 20(1):148. PubMed ID: 31477036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
    Skadrić I; Stojković O
    Int J Legal Med; 2020 Mar; 134(2):433-439. PubMed ID: 31858263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of genetic polymorphisms of cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in Turkish children.
    Seven M; Batar B; Unal S; Yesil G; Yuksel A; Guven M
    Mol Diagn Ther; 2014 Apr; 18(2):229-36. PubMed ID: 24338437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
    Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
    Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy.
    Manna I; Gambardella A; Labate A; Mumoli L; Ferlazzo E; Pucci F; Aguglia U; Quattrone A
    Seizure; 2015 Jan; 24():124-6. PubMed ID: 25458099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population.
    Ota T; Kamada Y; Hayashida M; Iwao-Koizumi K; Murata S; Kinoshita K
    Int J Med Sci; 2015; 12(1):78-82. PubMed ID: 25552922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
    Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
    Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Supervised Machine Learning Algorithms and Computational Structural Validation of Single Nucleotide Polymorphisms Related to Acute Liver Injury with Paracetamol.
    Sridharan K; Balasundaram A; Kumar DT; Doss CGP
    Curr Drug Metab; 2023; 24(10):684-699. PubMed ID: 37927072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter gene variation and refractory mesial temporal epilepsy with hippocampal sclerosis.
    Kauffman MA; Consalvo D; Gonzalez-Morón D; Aguirre F; D'Alessio L; Kochen S
    Epilepsy Res; 2009 Aug; 85(2-3):231-4. PubMed ID: 19375285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to confirm association of a polymorphism in KCNMB4 gene with mesial temporal lobe epilepsy.
    Manna I; Labate A; Mumoli L; Ferlazzo E; Aguglia U; Quattrone A; Gambardella A
    Epilepsy Res; 2013 Sep; 106(1-2):284-7. PubMed ID: 23623847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
    Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
    J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
    de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
    OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of CYP2C9, CYP2C19, and CYP2D6 Polymorphisms in Allergic Patients with Chemical Sensitivity.
    D'Attis S; Massari S; Mazzei F; Maio D; Vergallo I; Mauro S; Minelli M; Bozzetti MP
    Int Arch Allergy Immunol; 2019; 179(3):173-186. PubMed ID: 30943525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole mitochondrial DNA variations in hippocampal surgical specimens and blood samples with high-throughput sequencing: a case of mesial temporal lobe epilepsy with hippocampal sclerosis.
    Azakli H; Gurses C; Arikan M; Aydoseli A; Aras Y; Sencer A; Gokyigit A; Bilgic B; Ustek D
    Gene; 2013 Oct; 529(1):190-4. PubMed ID: 23872536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population.
    Hahn M; Müller DJ; Roll SC
    Pharmacopsychiatry; 2021 Mar; 54(2):81-89. PubMed ID: 33327018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 1A1, 2C9, 2C19, and 3A4 Polymorphisms Account for Interindividual Variability of Toxicological Drug Metabolism in Cynomolgus Macaques.
    Uno Y; Uehara S; Murayama N; Yamazaki H
    Chem Res Toxicol; 2018 Dec; 31(12):1373-1381. PubMed ID: 30412386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects.
    Tanno LK; Kerr DS; dos Santos B; Talib LL; Yamaguti C; Rodrigues H; Gattaz WF; Kalil J
    PLoS One; 2015; 10(8):e0136141. PubMed ID: 26291084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.